investment analyst coverage BTIG Initiates Coverage of Cue Health With Buy Rating The investment bank said the company is well positioned to take shares from reference labs and other point-of-care testing companies. Piper Sandler Initiates Coverage of Cytek Biosciences With Overweight Rating The investment bank said that Cytek was well positioned to remain one of the fastest growing life science tools companies, thanks to its light-based cell analysis technology. JP Morgan, Cowen Initiate Coverage of Sophia Genetics With Overweight, Outperform Ratings Both investment banks are bullish on the genomic data analysis firm, which went public on the Nasdaq a month ago, raising $234 million in gross proceeds. BTIG Initiates Coverage of DermTech With Buy Rating The investment bank said DermTech's pigmented lesion assay for the early detection of melanoma is well positioned in an estimated $3 billion-plus market. SVB Leerink, BTIG Initiate Coverage of Olink With Outperform, Buy Ratings Both firms highlighted the company's proximity extension assay technology and its ability to provide highly multiplexed proteomic analyses. Apr 1, 2021 GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock Mar 9, 2021 Investment Banks Initiate Coverage of Talis Biomedical With Bullish Outlooks Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Mar 2, 2021 Oppenheimer Initiates Coverage of MDxHealth at Outperform Mar 2, 2021 William Blair Initiates Coverage of Point-of-Care MDx Firm Lucira Health With Outperform Rating Jan 22, 2021 Oppenheimer Initiates Coverage of DermTech With Outperform Rating Jan 12, 2021 Cowen, SVB Leerink Initiate Coverage of 908 Devices With Outperform Ratings Jan 5, 2021 GenomeWeb Index Gains 49 Percent in 2020, Outperforming Wider Markets Dec 29, 2020 Cowen, JP Morgan Initiate Coverage of Seer With Outperform, Overweight Ratings Dec 28, 2020 M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Dec 14, 2020 Craig-Hallum Initiates Coverage of DermTech With Buy Rating Dec 11, 2020 BTIG Initiates Coverage of NeoGenomics With Buy Rating Dec 1, 2020 Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth Nov 30, 2020 BTIG Initiates Coverage of Oncocyte With Buy Rating Nov 23, 2020 Three Investment Banks Initiate Coverage of Biodesix Nov 5, 2020 Personalis Q3 Revenues Up 16 Percent Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 23, 2020 BTIG Initiates Coverage of Progenity With Buy Rating Oct 14, 2020 JP Morgan Rates Invitae Neutral Oct 13, 2020 Palmetto Cease-and-Desist Letter to Reimbursement Expert Raises Questions About Pricing Transparency Premium Load More Breaking News 23andMe to Acquire Telemedicine Platform Company Lemonaid Health for $400M in Cash, Stock UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.